A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
PHASE2CompletedINTERVENTIONAL
Enrollment
43
Participants
Timeline
Start Date
December 31, 2013
Primary Completion Date
April 28, 2017
Study Completion Date
April 28, 2017
Conditions
Colorectal Cancer
Interventions
DRUG
Simvastatin
Trial Locations (1)
Unknown
Samsung Medical Center, Seoul
All Listed Sponsors
lead
Samsung Medical Center
OTHER
NCT02026583 - A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter